PRB2 and gastric cancer: They found relations between the levels of PRB2, SERPINA1, Elastase 3A, CystD, and CELA3B expression in GC progression (4) They believed that three-biomarker panel of CystD+PepA-Ela3A could be sufficient for GC diagnosis with 95.7% sensitivity.